CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Global Lewy Body Dementia Treatment Market Size study, by Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, Modafinil) by Application Type (Parkinson’s Disease, Alzheimer’s Disease) by Mode of Purchase (Prescription and Over the Counter) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028 Global Lewy Body Dementia Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a ... Read More
-
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028
... Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is valued approximately USD ... Read More
-
Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA) and Others), by Route of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028
... of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028 Global Johnson Neuroectodermal Syndrome Market is valued approximately USD XX billion in 2022 and is anticipated ... Read More
-
U.S. Hospice Market Size, Share & Trends Analysis Report By Location (Hospice Center, Home Hospice Care), By Type (RHC, CHC), By Diagnosis (Dementia, Cancer, Respiratory, Stroke), And Segment Forecasts, 2022 - 2030
... a CAGR of 8.20% over the forecast period. The rising healthcare expenditure, awareness about the benefits of palliative and end-of-life care, and favorable reimbursements are some of the major growth drivers. According to the NHPCO, ... Read More
-
Veterinary Imaging Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Orthopedics & Traumatology, Obstetrics & Gynecology, Oncology, Cardiology, Neurology, Dentistry, Others); By Product; By Animal Type; By End-Use; By Region; Segment Forecast, 2022 - 2030
... - 2030 The global veterinary imaging market size is expected t-reach USD 2.99 billion by 2030 according t-a new study by Polaris Market Research. The report “Veterinary Imaging Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Schizophrenia Drugs Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
... illness that harms a person's lifestyle. Furthermore, schizophrenic patients have a distorted perception of reality. The condition causes a variety of behavioral alterations, such as grouping hallucinations, delusions, and so forth. As a result, medicine ... Read More
-
Neuromodulation Market By Technology (Internal Neuromodulation, External Neuromodulation), By Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), By Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), : Global Opportunity Analysis and Industry Forecast, 2020-2030
... : Global Opportunity Analysis and Industry Forecast, 2020-2030 The global neuromodulation market was valued at $2,480.2 million in 2020, and is projected to reach $4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 ... Read More
-
Migraine - Pipeline Insight, 2022
... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Migraine: Understanding Migraine: Overview Migraine is ... Read More
-
Nanomedicine Market (Application: Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, and Others [Dental, Orthopedic, Urology, and Ophthalmic]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... the global nanomedicine market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides ... Read More
-
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), ... Read More
-
Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Fibromyalgia (Central Nervous System) pipeline landscape. Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, ... Read More
-
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Down Syndrome (Genetic Disorders) pipeline landscape. Down syndrome is a genetic disorder that causes lifelong mental retardation, developmental delays and ... Read More
-
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no ... Read More
-
Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Treatment and Diagnosis [Magnetic Resonance Imaging, Computed Tomography Scan, X-Rays, and Others]), End User (Hospital & Clinics, Diagnostic Centers, and Others), Geography
... The concussion market is expected to growth from US$ 7,211.89 million in 2021 to US$ 9,272.03 million by 2028. It is estimated to grow at a CAGR of 3.7% during 2021–2028. According to the Centers ... Read More
-
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Tourette Syndrome (Central Nervous System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Other Applications] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% ... Read More
-
Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, and Other Rare Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $1,40,000.0 million in 2020 and is projected to reach $4,35,686.3 million by 2030 registering a CAGR of 11.8% from 2021 to 2030. The pharmaceutical agents administered to treat, diagnose, and prevent life-threatening diseases ... Read More
-
Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022
... provides top line data relating to the clinical trials on Carpal Tunnel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Alcohol Addiction - Global Clinical Trials Review, 2022
... data relating to the clinical trials on Alcohol Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorders (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleepwalking, and Other Sleep Disorders): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Forecast, 2021–2030 The global sleep aids market was valued at $59,815.10 million in 2020, and is projected to reach $111,920.10 million by 2030, registering a CAGR of 6.9%from 2021 to 2030. Sleep is a biological ... Read More
-
Brain Health Supplements Market by Age Group (Children, Adults, and Elderly), Product (Herbal Extract, Vitamins & Minerals, and Natural Molecules), Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-Aging, Sleep & Recovery, and Anxiety), Supplement Form (Tablets, Capsules, and Others), and Sales Channel (Supermarkets & Hypermarkets, Drug Stores, Online Stores, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... and Anxiety), Supplement Form (Tablets, Capsules, and Others), and Sales Channel (Supermarkets & Hypermarkets, Drug Stores, Online Stores, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global brain health supplement market was valued ... Read More
-
Nanotechnology Drug Delivery Market (Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; and Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Market – Scope of Report TMR’s report on the global nanotechnology drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the ... Read More
-
2022 Global Forecast for Nerve Repair And Regeneration (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is estimated to ... Read More
Research Assistance
